Alnylam Pharmaceuticals reported $366.71M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 158.93M 14.4M
Agios Pharmaceuticals AGIO:US $ 89.22M 2M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 366.71M 2.89M
Amgen AMGN:US $ 5.7B 1.93B
Arena Pharmaceuticals ARNA:US $ 144.39M 12.4M
Arrowhead Research ARWR:US $ 77.76M 16.72M
Avrobio Inc AVRO:US 31.38M 4.49M
Biocryst Pharmaceuticals BCRX:US $ 79.54M 9.1M
Biomarin Pharmaceutical BMRN:US $ 490.02M 29.08M
Bluebird Bio BLUE:US $ 248.31M 4.31M
Dicerna Pharmaceuticals DRNA:US $ 81.58M 4.87M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Intercept Pharmaceuticals ICPT:US $ 95.82M 15.19M
IONIS PHARMACEUT IONS:US $ 207.35M 3.77M
Mirati Therapeutics MRTX:US $ 164.19M 31.76M
Moderna Inc MRNA:US 1.29B 621M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Novartis NVS:US 9.82B 464M
Ptc Therapeutics PTCT:US $ 215.17M 921K
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M
Regulus Therapeutics RGLS:US $ 6.64M 840K
Sangamo Biosciences SGMO:US $ 76.57M 3.99M
Sarepta Therapeutics SRPT:US $ 331.66M 32.87M
Ultragenyx Pharmaceutical RARE:US $ 169.75M 36.21M
Vertex Pharmaceuticals VRTX:US $ 1831.33M 994.85M
Xencor XNCR:US $ 58.36M 8.72M
YTE INCY:US $ 564.87M 58.95M